Sign up for our daily briefing
Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.
Stay on top of the latest market trends
Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.
Sports news worthy of your time
Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.
Tech news worthy of your time
Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.
Get the inside stories
Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Want a daily digest of the top Denver news?
Get a daily digest of the most important stories affecting your hometown with Axios Denver
Want a daily digest of the top Des Moines news?
Get a daily digest of the most important stories affecting your hometown with Axios Des Moines
Want a daily digest of the top Twin Cities news?
Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities
Want a daily digest of the top Tampa Bay news?
Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay
Want a daily digest of the top Charlotte news?
Get a daily digest of the most important stories affecting your hometown with Axios Charlotte
Anthony Fauci speaks at a Feb. 7 press conference on coronavirus developments. Photo: Samuel Corum/Getty Images
A leading U.S. health official said Tuesday it's "very frustrating" that no major drug firm has yet offered to make a vaccine against the novel coronavirus that the National Institutes of Health is helping develop, STAT News reports.
Why it matters: When outbreaks of new worrisome pathogens start, governments may immediately start working on diagnostics, vaccines and treatments, but they also need a buy-in from drug companies that sometimes get burned if the outbreak suddenly peters out or the drug isn't successful.
Details: National Institute of Allergy and Infectious Diseases director Anthony Fauci said on a panel hosted by STAT and the Aspen Institute that it'd take "at least a year" before a coronavirus vaccine could become available — and that's assuming a pharmaceutical manufacturing giant were to produce the product.
- Fauci noted that although the NIH had partnered with Moderna to develop a COVID-19 vaccine, a large manufacturer would be needed to "take on the risky venture of manufacturing the product if it is successful in human testing," according to an S&P Global report of the panel discussion.
- "The companies that have the skill to be able to do it ... [are] going to have to stop making polio vaccines, measles vaccines, hepatitis vaccines to put your particular product in," Fauci said, per S&P Global.
The big picture: Several U.S. pharmaceutical firms have said they're working on their own vaccines against the new coronavirus, which has killed over 1,1100 people and infected more than 45,000 others — mostly in mainland China. These include Inovio, Johnson & Johnson and Novavax, according to the State Department.
What they're saying: Johnson & Johnson said Tuesday its Janssen Pharmaceutical Companies would "further expedite its investigational coronavirus vaccine program" in collaboration with HHS'' Biomedical Advanced Research and Development Authority.
- "This partnership will ensure that vital research is made possible at rapid speed and underscores the importance of public-private partnerships to tackle the worldwide novel coronavirus epidemic," Paul Stoffels, vice chairman of the executive committee and chief scientific officer at Johnson & Johnson, said in a statement.
- "We are also in discussions with other partners, that if we have a vaccine candidate with potential, we aim to make it accessible to China and other parts of the world."
Go deeper: